Analyst picks & changes

Interneuron Pharmaceuticals Inc.

(IPIC)

Patricia Lea of Argo Analysis said she thinks it likely that IPIC's dexfenfluramine anti-obesity drug will be approved. The Lexington,

Read the full 248 word article

How to gain access

Continue reading with a
two-week free trial.